Dronedarone  Tablets

400 mg



Dronedarone is indicated for treating and preventing a number of types of cardiac dysrhythmias.
Being the newer version of Amiodarone, Unipharm’s generic Dronedarone Tablets were launched in Israel in 2020.
Dronedarone Tablets are available for EU submission with an early launch. The Dossier includes a new EU bioequivalence study compared to the EU Reference Listed Drug, Multaq.

  • ATC4: C01BD
  • Strengths: 400 mg
  • Dosage form: Tablets
  • Out-licensing is offered for all international markets*
  • EU Dossier is available for submission
* Product availability is subject to patent restrictions in countries where applicable patents are in effect

related products